- Jul 28, 2022
Gene That Causes Deadliest Brain Tumor Also Causes Childhood Cancer
A gene that UVA Health researchers discovered is responsible for the deadliest type of brain tumor is also responsible for two forms of childhood cancer, the scientists have found. Read more: https://newsroom.uvahealth.com/2022/07/27/gene-that-causes-deadliest-brain-tumor-also-causes-childhood-cancer/
- Jul 26, 2022
Cardiovascular disease, not cancer, top cause of death among Hodgkin lymphoma survivors
Patients with early-stage classic Hodgkin lymphoma and other neoplasms exhibited higher risk for cardiovascular disease-associated mortality compared with cancer-associated mortality later in life, according to study results. Read more: https://www.healio.com/news/hematology-oncology/20220725/earlystage-hodgkin-lymphoma-survivors-at-increased-risk-for-cardiovascular-disease
- Jul 19, 2022
Why Do Pediatric Drugs Take So Long to Develop?
When it comes to treatment for cancer, and many chronic conditions in children, it often takes much longer to get new drugs and therapies approved. This is due to a lack of clinical studies needed to approve these innovative treatments. Read more: https://www.survivornet.com/articles/why-do-pediatric-drugs-take-so-long-to-develop-a-look-into-the-lag-time-on-drug-approvals-for-childhood-cancer-other-illnesses/
- Jul 18, 2022
Brain Cancer Therapy Shows Promise in Pediatric Clinical Trial
A new antibody therapy for children with medulloblastoma has shown promise during a Phase I clinical trial. The antibody, which targets a protein that enables cancer cells to multiply and spread, was well tolerated and helped to stabilize the disease, helping to preserve the patients’ quality of life. Read more: https://www.genengnews.com/topics/cancer/brain-cancer-therapy-shows-promise-in-pediatric-clinical-trial/
- Jul 14, 2022
Study reveals a new therapeutic target for aggressive type of rhabdomyosarcoma
Scientists at St. Jude Children’s Research Hospital have identified an Achilles’ heel in rhabdomyosarcoma driven by a gene fusion which revealed a promising treatment approach in the lab. Read more: https://www.stjude.org/media-resources/news-releases/2022-medicine-science-news/new-therapeutic-target-for-aggressive-type-of-rhabdomyosarcoma.html
- Jul 12, 2022
Study identifies kids with cancer at risk of lethal infections
Researchers have identified the child cancer patients at greatest risk of developing life-threatening infections, in a crucial step towards the development of an early diagnostic test. Read more: https://www.sciencedaily.com/releases/2022/07/220712102716.htm
- Jul 11, 2022
Study identifies chromosomal abnormalities associated with relapse in frequent subtype of childhood
An international research team coordinated by Dr. Oscar Molina and Dr. Pablo Menéndez, from the Josep Carreras Leukaemia Research Institute, identifies chromosomal abnormalities associated to relapse in a frequent subset of B-cell Acute Lymphoblastic Leukemia (B-ALL), a severe condition affecting especially children. This finding may help identify those patients at a higher risk of relapse at diagnosis to direct them to more appropriate treatment options and anticipate
- Jul 6, 2022
Nonsurgical approach for treatment of children with rare skull tumor
Surgery can usually be avoided in children with a rare tumor of the skull, based on new research by investigators from Weill Cornell Medicine, NewYork-Presbyterian, Nicklaus Children's Hospital, the University of Texas Southwestern, the University of British Columbia and McGovern Medical School. Read more: https://www.news-medical.net/news/20220630/Nonsurgical-approach-for-treatment-of-children-with-rare-skull-tumor.aspx
- Jul 5, 2022
Harnessing a virus to fight a killer brain tumor in kids
A therapy that uses a virus to kill tumor cells can be safely given to children with a rare, incurable form of brain cancer, an early study has found. Read more: https://medicalxpress.com/news/2022-06-harnessing-virus-killer-brain-tumor.html
- Jul 4, 2022
Taking Stock of Breakthroughs and Struggles in Pediatric Cancer Care
Despite many treatment advances, about 10,500 children under age 15 are diagnosed with cancer each year, according to statistics from the American Cancer Society. And while new approaches to care have improved overall survival rates, cancer is still the No. 1 cause of death by disease for kids. Read more: https://www.usnews.com/news/health-news/articles/2022-07-01/taking-stock-of-breakthroughs-and-struggles-in-pediatric-cancer-care